Send feedback

SGMS2 p.Ser213Phe

c.638C>T · VCV3631039

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely pathogenic
0.7856 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00134%, afr)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call

⚠ Built without this gene's context — gene constraint and dosage, protein structure, pathways, panels and related-variant links were not looked up for this page. why

Computational evidence

Protein change
AlphaMissense0.7856likely pathogenic
REVEL0.529indeterminate
SaProtLLR -14.07damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not looked up on this page · why
Constraint at this position
ConservationphyloP 7.6GERP 2.9, phastCons 1
Regional constrainto/e 0.87unconstrained · MANE · 15 kb · p 0.0049 · regional, not allelic
Overall
CADD28.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00134% African / African-American · 1/74,904 alleles
Overall 6.2e-05% 1/1,613,808 alleles · very rare exomes 0/1,461,672 · genomes 1/152,136 · joint denominator

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SGMS2
Protein
p.Ser213Phe
Coding
c.638C>T
MANE Select
NM_001375905
Type
single nucleotide variant
Location
chr4:107903297 (GRCh38)
Full SGMS2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/sgms2-p-ser213phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown